» Articles » PMID: 15667128

Enrichment of Ligands for the Serotonin Receptor Using the Shape Signatures Approach

Overview
Date 2005 Jan 26
PMID 15667128
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Shape Signatures, a new 3-dimensional molecular comparison method, has been adapted to rank ligands of the serotonin receptors. A set of 825 agonists and 400 antagonists together with approximately 10,000 randomly chosen compounds from the NCI database were used in this study. Both 1D and 2D Shape Signature databases were created, and enrichment studies were carried out. Results from these studies reveal that the 1D Shape Signature approach is highly efficient in separating agonists from a mixture of molecules which includes compounds randomly selected from the NCI database taken as inactives. It is also equally effective at separating agonists and antagonists from a pool of active ligands for the serotonin receptor. Parallel enrichment studies using 2D shape signatures showed high selectivity with more restricted coverage due to the high specificity of 2D signatures. The influence of conformational variation of the shape signature on enrichment was explored by docking a subset of ligands into the crystal structure of serotonin N-acetyltransferase. Enrichment studies on the resulting "docked" conformations produced only slightly improved results compared with the CORINA-generated conformations.

Citing Articles

QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Yu Y, Dong H, Peng Y, Welsh W Molecules. 2021; 26(17).

PMID: 34500703 PMC: 8434483. DOI: 10.3390/molecules26175270.


Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery.

Kumar A, Zhang K Front Chem. 2018; 6:315.

PMID: 30090808 PMC: 6068280. DOI: 10.3389/fchem.2018.00315.


Avalanche for shape and feature-based virtual screening with 3D alignment.

Diller D, Connell N, Welsh W J Comput Aided Mol Des. 2015; 29(11):1015-24.

PMID: 26458937 DOI: 10.1007/s10822-015-9875-y.


Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.

Ai N, Wood R, Welsh W Pharm Res. 2015; 32(8):2798-807.

PMID: 25762088 DOI: 10.1007/s11095-015-1665-7.


Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery.

Zauhar R, Gianti E, Welsh W J Comput Aided Mol Des. 2013; 27(12):1009-36.

PMID: 24366428 PMC: 3880490. DOI: 10.1007/s10822-013-9698-7.